Positive staining for neuroendocrine markers (NSE, synaptophysin, chromogranin A) and negative staining for lymphoid (CD3, Pax5) and nephroblastoma (WT1) markers were pivotal in confirming the tumor’s neuroendocrine origin. The gene discussed is CHGA; the disease is neoplasm.